{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:21:36Z","timestamp":1774628496632,"version":"3.50.1"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.2169\/internalmedicine.2997-19","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T18:03:41Z","timestamp":1561572221000},"page":"2983-2988","source":"Crossref","is-referenced-by-count":14,"title":["Renin-angiotensin System Blockade Therapy for Early Renal Involvement in MYH9-related Disease with an E1841K Mutation"],"prefix":"10.2169","volume":"58","author":[{"given":"Mari","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirona","family":"Saita","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seira","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Hagihara","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachio","family":"Iwanari","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kunishima","sequence":"additional","affiliation":[{"name":"Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan"},{"name":"Department of Medical Technology, Gifu University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Takeoka","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Hyogo Prefectural Amagasaki General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kunishima S, Kojima T, Matsushita T, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly\/Sebastian syndrome). Blood 97: 1147-1149, 2001.","DOI":"10.1182\/blood.V97.4.1147"},{"key":"2","unstructured":"2. Information Center for Specific Pediatric Chronic Diseases, Japan. May-Hegglin anomaly [Internet]. [cited 2019 Mar 26]. Available from: https:\/\/www.shouman.jp\/disease\/details\/09_18_030\/ (in Japanese)."},{"key":"3","unstructured":"3. Pecci A, Klersy C, Gresele P, et al. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat 35: 236-247, 2014."},{"key":"4","unstructured":"4. Kunishima S, Matsushita T, Kojima T, et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83: 115-122, 2003."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 10: 778-790, 2009.","DOI":"10.1038\/nrm2786"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sekine T, Konno M, Sasaki S, et al. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease. Kidney Int 78: 207-214, 2010.","DOI":"10.1038\/ki.2010.21"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cechova S, Dong F, Chan F, Kelley MJ, Ruiz P, Le TH. MYH9 E1841K mutation augments proteinuria and podocyte injury and migration. J Am Soc Nephrol 29: 155-167, 2018.","DOI":"10.1681\/ASN.2015060707"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Zhang Y, Conti MA, Malide D, et al. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood 119: 238-250, 2012.","DOI":"10.1182\/blood-2011-06-358853"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kopp JB. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism? Kidney Int 78: 130-133, 2010.","DOI":"10.1038\/ki.2010.82"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol 154: 161-174, 2011.","DOI":"10.1111\/j.1365-2141.2011.08716.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hao J, Kunishima S, Guo X, Hu R, Gao W. A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts. Ann Hematol 91: 1147-1148, 2012.","DOI":"10.1007\/s00277-011-1370-5"},{"key":"12","unstructured":"12. Hashimoto J, Hamasaki Y, Takahashi Y, et al. Management of patients with severe Epstein syndrome: a review of four patients who received living-donor renal transplantation. Nephrology (Carlton) 24: 450-455, 2019."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Oh T, Jung Seo H, Taek Lee K, et al. MYH9 nephropathy. Kidney Res Clin Pract 34: 53-56, 2015.","DOI":"10.1016\/j.krcp.2014.09.003"},{"key":"14","unstructured":"14. Ishida M, Mori Y, Ota N, Inaba T, Kunishima S. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature. Clin Nephrol 80: 218-222, 2013."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Han KH, Lee H, Kang HG, et al. Renal manifestations of patients with MYH9-related disorders. Pediatr Nephrol 26: 549-555, 2011.","DOI":"10.1007\/s00467-010-1735-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pecci A, Granata A, Fiore CE, Balduini CL. Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). Nephrol Dial Transplant 23: 2690-2692, 2008.","DOI":"10.1093\/ndt\/gfn277"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Capria M, Andreucci M, Fuiano L, et al. Double nucleotidic mutation of the MYH9 gene in a young patient with end-stage renal disease. Nephrol Dial Transplant 19: 249-251, 2004.","DOI":"10.1093\/ndt\/gfg475"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_2997-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T23:34:33Z","timestamp":1571441673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_2997-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":17,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2997-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}